2-(Morpholinomethyl)-5-nitroisoindoline-1,3-dione

Catalog No. :
ACINZM054
CAS No. :
301210-82-2
Molecular Formula :
C13H13N3O5
Molecular Weight :
291.26

IUPAC Name:2-(morpholinomethyl)-5-nitroisoindoline-1,3-dione

2-(Morpholinomethyl)-5-nitroisoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$182.00Login to see priceIn stockInquiry
250mg98%$311.00Login to see priceIn stockInquiry
1g98%$838.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Morpholinomethyl)-5-nitroisoindoline-1,3-dione
IUPAC Name2-(morpholinomethyl)-5-nitroisoindoline-1,3-dione
Molecular FormulaC13H13N3O5
Molecular Weight291.26
SMILESO=C1N(CN2CCOCC2)C(C3=C1C=CC([N+]([O-])=O)=C3)=O
InChI KeyCWKLCBJZEKEMMS-UHFFFAOYSA-N
Synonym2-(morpholinomethyl)-5-nitroisoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-(4-morpholinylmethyl)-5-nitro-;GI-570310
CAS No.301210-82-2
PubChem CID739705

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACINZM054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACIEJS693 route compound structure diagram
    ACIEJS69389-40-7 In Stock
  6. Then
  7. ACINZM054 route product structure diagram
    ACINZM054301210-82-2 In Stock
Inquiry

2. ACINZM054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACINZM054 route product structure diagram
    ACINZM054301210-82-2 In Stock
Inquiry

Comments (0)